
Matice Founder Jessica Whited on Harnessing Regenerative Species for Medical Breakthroughs - Ep. 198
NVIDIA AI Podcast
00:00
The Benefits of Turning Proteins Into Peptides
In the very long term, we should think of Matisse as a regenerative medicine company. We should have a broad perspective on what these super generators could be used for. And we should also keep our eye on the molecules that we do take into formulations for topical treatments. Any of the information we learn about them and studying their effects on human cells may provide a path forward for how we might repurpose them with additional studies for internal organs. It's been noted that perhaps somewhere around 40, 45% of deaths in the United States are attributed to organ fibrosis or some underlying fibrotic conditions. So I think that market is really super huge.
Transcript
Play full episode